期刊文献+

门静脉高压症脾亢患者外周血CD4^(+)CD25^(+)CD127^(low/-)调节性T细胞含量与免疫功能研究 被引量:2

Research on the content and the immune function of CD4^(+)CD25^(+)CD127^(low/-) regulatory T cells in peripheral blood of patients with portal hypertension and hypersplenism
下载PDF
导出
摘要 目的研究门静脉高压症(PHT)脾亢患者外周血CD4+CD25+CD127low/-调节性T细胞(Treg)与CD3+、CD4+、CD8+T细胞的表达变化,探讨脾脏免疫功能改变及其可能的调节机制。方法PHT脾亢患者20例(脾亢组),健康成人18例(对照组),采用流式细胞术检测外周血中CD4+CD25+CD127low/-Treg及CD3+、CD4+、CD8+T细胞的表达变化。结果脾亢组外周血中CD4+CD25+CD127low/-Treg占CD4+T细胞的比例为(5.3±3.0)%,明显高于对照组的(2.5±0.9)%(P<0.01)。脾亢组CD3+、CD4+、CD8+T细胞含量均低于对照组(P<0.05)。CD4+CD25+CD127low/-Treg的含量与CD3+T细胞比例呈负相关(r=-0.630,P<0.01),与CD4+T细胞比例呈负相关(r=-0.561,P<0.05)。结论PHT脾功能亢进患者CD4+CD25+CD127low/-调节性T细胞表达量增多,可能对脾脏免疫功能的调节有重要作用。 Objective To investigate the changes of expression of CD4+CD25+CD127low/-regulatory T cells and CD3+,CD4+,CD8+ T cell in peripheral blood of patients with portal hypertension(PHT) and hyper-splenism,explore the changes in splenic immune function and its possible regulative mechanism.Methods The ratios of CD4+CD25+CD127low/-Treg and CD3+,CD4+,CD8+ T cell in peripheral venous blood were exam-ined with flow cytometry in 20 patients with PHT and hypersplenism,and compared with 18 healthy individuals.Results The ratios of CD4+CD25+CD127low/-/CD4+ in PHT group were(5.3±3.0)%.It was significantly in-creased compared with healthy group(2.5±0.9)%(P0.01).The ratios of CD3+,CD4+,CD8+ T cells were decreased in patients with PHT compared with healthy group(P0.05).There was a negative correlation between CD4+CD25+CD127low/-and CD3+,CD4+(r=-0.630,P0.01;r=-0.561,P0.05).Conclusion The expression of CD4+CD25+CD127low/-Treg are significantly increassed in patients with PHT and hypersplenism,it may play an important role in splenic immunomodulatory.
出处 《肝胆胰外科杂志》 CAS 2010年第2期89-91,共3页 Journal of Hepatopancreatobiliary Surgery
基金 浙江省外科学重中之重学科基金资助项目
关键词 高血压 门静脉 脾亢 CD4+CD25+CD127low/-调节性T细胞 免疫功能 hypertension portal hypersplenism CD4+CD25+CD127low/-regulatory T cells immune function
  • 相关文献

参考文献9

  • 1Liu WH,Putnam AL,Zhou XY,et al.CD127 expression inveresely correlates with FoxP3 and auppressive function of human CD4+ T reg cells[J].J Exp Med,2006,203(7):1701-1711.
  • 2Shevach EM.CD4+CD25+ suppressor T cells:more questions than answers[J].Nat Rev Immunol,2002,2(6):389-400.
  • 3Ramsdell F,Ziegler SF.Transcription factors in autoimmunity[J].Curr Opin in Immunol,2003,15(6):718-724.
  • 4Sakaguchi S.The origin of FOXP3 expressing CD4+ regulatory T cells:thymus or periphery[J].J Clin Invest,2003,112(9):1310-1312.
  • 5Morgan ME,van Bilsen JH,Bakker AM,et al.Expression of FOXP3 mRNA is not confiened to CD4+CD25+ T regulatory cells in humans[J].Hum Immunol,2005,66(1):13-20.
  • 6Seddiki N,Santner-Nanan B,Martinson J,et al.Expression of interleukin (IL)-2 and IL-7 receptors discnminates between human regulatory and activated T cell[J].J Exp Med,2006,20(3):1693-1700.
  • 7Hartigan-O'Connor DJ,Poon C,Sinclair E,et al.Human CD4+regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127),allowing consistent identification and sorting of live cells[J].J Immunol Meth,2007,319 (1-2):41-52.
  • 8吴仕和,仇登波,黄韬.门脉高压症患者脾脏免疫学研究[J].湖南医学,2001,18(1):1-4. 被引量:12
  • 9姜洪池,乔海泉,代文杰.脾脏外科:近20年的进展与展望[J].中华肝胆外科杂志,2002,8(1):3-6. 被引量:71

二级参考文献16

共引文献81

同被引文献33

  • 1谭立清,黄中华,张庆敏,刘燕洁,黄小彬,秦丹丹.血液稀释与输异体血对肝癌病人T细胞亚群的影响[J].广西医学,2006,28(10):1501-1502. 被引量:2
  • 2Kondlkovd K, Vokurkovei D, Krejsek J, et al. Regulatory T ceils (TREG) and their roles in immune system with respect to immuno- pathological disorders[J]. Acta Medica (Hradec Kralove) ,2010,53 (2) ;73-77.
  • 3Weng J, Lai P, Lv M, et al. Bortezomih modulates regulatory T cell subpopulations in the process of acute graft-versus-host dis- ease[J]. Clin Lab, 2013,59(1-2) :51-58.
  • 4Bremm M, Huenecke S, Lehrnbecher T, et al. Advanced flowcy- tometrc analysis of regulatory T cells CD127 downregulation early post stem cell transplantation and altered Treg/CD3 (+) CD4(+)-ratio in severe GvHD or relapse[J]. J Immunol Meth- ods,2011,373(1-2) :36-44.
  • 5Sakaguchi S,Yamaguchi T,Nomura T,et al. Regulatory T cells and immune tolerance/J],' Cell, 2008,133 (5) : 775-787.
  • 6Bilate AM, Lafaille JJ. Induced CD4+ Foxp3+ regulatory T cells in immune tolerance[J]. Annu Rev Immunol, 2012,30 : 733-758.
  • 7Josefowicz SZ,Lu LFRudensky AY. Regulatory T Cells:Mech- anisms of differentiation and function[J]. Annu Rev Immunol,2012,30:531-564.
  • 8Schlecker E, Stojanovic A, Eisen C, et al. Tumor-infiltrating mono- cytic myeloiaUderived suppressor cells mediate CCRS-dependent re- cruitment of regulatory T cells favoring tumor growth[J]. J Immu- nol,2012,189(12) ,5602-5611.
  • 9Hori S, Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3 [J]. Science, 2003,299(5609) ,1057- 1061.
  • 10Nishikawa H,Sakaguehi S. Regulatory T cells in tumor immuni- ty[J]. Int J Cancer, 2010,127(4) : 759-767.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部